0001179110-20-006611.txt : 20200526
0001179110-20-006611.hdr.sgml : 20200526
20200526205233
ACCESSION NUMBER: 0001179110-20-006611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200521
FILED AS OF DATE: 20200526
DATE AS OF CHANGE: 20200526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holles Natalie C.
CENTRAL INDEX KEY: 0001580111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 20912524
MAIL ADDRESS:
STREET 1: C/O HYPERION THERAPEUTICS, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2020-05-21
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001580111
Holles Natalie C.
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY STREET, SUITE 300
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
6.22
2020-05-21
4
A
0
25000
0.00
A
2030-05-20
Common Stock
25000
25000
D
This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service.
/s/ Joanne M. Protano, Attorney-in-Fact
2020-05-26